Evidence map›Paper›PMID 40296451›Full record

ArticleWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

Impact of malodour on health-related quality of life of patients with chronic wounds due to volatile organic compounds.

E K Stuermer, C Nathrath, H Lober, M Wigger, T M Janke, M Augustin, M Dittmer, S Sielemann, S C Liegenfeld

Abstract read
In one paragraph

Article in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Microbial volatile organic compounds and olfactory receptors in wound malodor.Frontiers in cellular and infection microbiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Impact of malodour on health-related quality of life of patients with chronic wounds due to volatile organic compounds.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

E K StuermerDepartment of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
C NathrathDepartment of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
H LoberHamm-Lippstadt University of Applied Sciences, Hamm, Germany.
M WiggerHamm-Lippstadt University of Applied Sciences, Hamm, Germany.ORCID 0009-0008-0159-3991
T M JankeInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID 0000-0002-9861-9519
M AugustinInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID 0000-0002-4026-8728
M DittmerDepartment of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
S SielemannHamm-Lippstadt University of Applied Sciences, Hamm, Germany.
S C LiegenfeldDepartment of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds significantly impact health-related quality of life (HRQoL). Unpleasant wound odour, caused by bacterial colonisation and necrotic processes, is a distressing symptom. Its exact composition is not well understood, but it could be the basis for a personalised odour avoidance strategy. Therefore, this feasibility study explored 92 wounds from 66 patients with the focus on wound odour, bacterial burden and their impact on health related-quality of life (HRQoL). Volatile organic compounds (VOCs) responsible for wound odours were detected at the molecular level, using gas chromatography-mass spectrometry and -ion mobility spectrometry and correlated to the HRQoL. In patients analysed (average age 69 ± 13 years, wound persistence 24.31 ± 70.8 months) 135 pathogens were identified by swabbing including 19% Staphylococcus aureus, 15% Pseudomonas aeruginosa and 35% Enterobacteria. The specific questionnaire 'Wound-QoL-14' showed a non-significant difference in HRQoL in patients with wound odour (2.1 ± 1.0 vs. 1.8 ± 1.0). The latter also had the highest number of VOC detections. The most frequently detected, relevant VOCs from prokaryotic sources were dimethyl-disulphide and diacetyl-(2,3-butanedione). Furthermore, potential biomarkers for specific pathogens were identified, including dimethyl-trisulphide for P. aeruginosa and indole for Escherichia coli. The most prevalent substance groups were ketones and alcohols. In conclusion, the malodour of chronic wounds is caused by a mixture of the intrinsic odour of bacterial products and necrosis. This exploratory study, which combines the analysis of decoded VOCs and the olfactory assessment of odour, could be a novel, targeted approach for identifying potential 'anti-wound odour therapies' that will significantly benefit the HRQoL of patients with malodourous tumour wounds, in particular.

Indexed as

OdorantsQuality of LifeVolatile Organic CompoundsWound HealingWound InfectionWounds and InjuriesAgedAged, 80 and overChronic DiseaseFeasibility StudiesFemaleGas Chromatography-Mass SpectrometryHumansMaleMiddle AgedPseudomonas aeruginosaVolatile Organic Compoundsbacteriachronic woundsHRQoLion mobility spectrometrywound infectionwound odour

Identifiers

PMID40296451
PMCPMC12038225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.